Terns Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TERN Nasdaq 8731 https://ternspharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Terns Pharmaceuticals Inc

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - Jun 2nd, 2023 8:05 pm
Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth - May 28th, 2023 1:45 pm
Terns Pharmaceuticals Announces Publication of TERN-701 Trial-in-Progress Abstract for the 2023 ASCO Annual Meeting - May 25th, 2023 9:05 pm
Terns Pharmaceuticals to Present at Upcoming Investor Conferences - May 24th, 2023 8:05 pm
Terns Pharmaceuticals to Highlight New Preclinical Data for TERN-601 Program in Obesity at the American Diabetes Association’s 83rd Annual Scientific Sessions - May 22nd, 2023 8:05 pm
Terns Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updates - May 15th, 2023 12:05 pm
Terns Pharmaceuticals to Participate in the JMP Securities 2023 Life Sciences Conference - May 9th, 2023 8:05 pm
Terns Pharmaceuticals, Inc. (TERN) Is Up 15.12% in One Week: What You Should Know - Apr 25th, 2023 4:00 pm
Why Shares of Terns Pharmaceuticals Soared This Week - Mar 30th, 2023 6:28 pm
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates - Mar 27th, 2023 8:05 pm
Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as Chief Medical Officer of Terns Oncology - Mar 27th, 2023 12:05 pm
Investing in Terns Pharmaceuticals (NASDAQ:TERN) a year ago would have delivered you a 211% gain - Mar 8th, 2023 10:26 am
Terns Pharmaceuticals Provides Program Updates and Announces Participation at Upcoming March Investor Conferences - Mar 2nd, 2023 9:05 pm
TipRanks ‘Perfect 10’ List: 3 Top-Rated Stocks That Tick All the Right Boxes - Feb 26th, 2023 3:51 pm
Are You Looking for a Top Momentum Pick? Why Terns Pharmaceuticals, Inc. (TERN) is a Great Choice - Feb 8th, 2023 5:00 pm
Terns Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2023 Oncology Conference - Feb 2nd, 2023 9:05 pm
Terns Pharmaceuticals to Present at B. Riley Securities’ 3rd Annual Oncology Conference - Jan 12th, 2023 9:05 pm
Terns Pharmaceuticals to Highlight 2023 Priorities and Clinical Milestones at the 41st Annual J.P. Morgan Healthcare Conference - Jan 5th, 2023 9:05 pm
Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - Dec 23rd, 2022 9:05 pm
Terns Announces Pricing of $75 Million Public Offering - Dec 21st, 2022 12:40 am